Many drug testing programs rely on urine or saliva collection, often chosen because they appear inexpensive. But what looks affordable on paper can become costly, especially once you factor in supervision, logistics, and downtime. To achieve cost-effective drug testing, it’s essential to look beyond unit price and assess how each method affects your operations. Fingerprint…
NEW YORK, June 11, 2025 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an update on its growing footprint in the U.S. Forensic Use Only Market through its strategic partnership with SMARTOX, a Texas-based leader in drug and alcohol screening services. SMARTOX supports…
Accuracy isn’t the only factor that matters when selecting a drug test for your work. You need a testing solution that balances reliability with convenience, protects employee privacy, and ensures your business stays compliant. This guide breaks down the key considerations and compares standard testing options, urine, saliva, and fingerprint sweat drug tests, to help you…
Random drug testing is vital to safety and compliance policies in many industries, from construction and manufacturing to transport and logistics. But while the aim is clear: preventing drug-related incidents before they happen, the execution can be complex. Traditional methods often involve delays, disruption, and uncomfortable collection processes. Fingerprint drug testing offers a practical alternative,…
NEW YORK, May 22, 2025 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its participation at the All Rise Conference, RISE25, in Kissimmee, Florida from May 28 to 31, 2025. The Company will support its U.S. distribution partner SMARTOX, showcasing INBS’ unique Intelligent…
NEW YORK, May 19, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a high-volume workforce drug test for Barcaldine Regional Council in remote Queensland, Australia, (the “Council”) using its Intelligent Fingerprinting Drug Screening System (the…
As workplace safety and compliance standards rise, more organizations are evaluating how drug testing is conducted and when it can detect use. One of the most common questions from health and safety teams is: how far back does fingerprint drug testing go? The answer lies in the science behind detection windows and why shorter, more…
NEW YORK, May 15, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced recent growth highlights across its global operations, driven by new account acquisitions, expansion into new testing areas and sectors, and continued penetration into safety-critical industries. The Company’s total…
NEW YORK, May 13, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for the fiscal third quarter and nine months ended March 31, 2025, and provided a business update. The Company delivered a strong quarter of…
Workplace drug testing protects employee well-being, reduces operational risk, and supports compliance. Testing programs must combine legal awareness with ethical responsibility to be effective and respected. As global attitudes toward drug use continue to evolve and regulations shift, employers must navigate a complex and often fragmented landscape. Responsible employers build testing programs that follow local…
NEW YORK, May 06, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of three new localized websites in Arabic, Italian, and Spanish. This rollout supports the Company’s global growth plans and international sales expansion by opening digital and…
In high-risk industries like construction, logistics, transport, manufacturing, and mining, the consequences of drug and alcohol misuse extend far beyond the individual. Even a single incident involving an impaired worker can have devastating consequences, with the potential for injury, operational disruption, and exposing companies to costly legal and reputational fallout. While some employers hesitate to…
NEW YORK, April 22, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the integration of Latin American Spanish into its Intelligent Fingerprinting Drug Screening System (the “System”). The enhancement allows users to operate the System in English, Arabic, and…
Testing for illicit drug use has been readily available since the 1960s. Initially, those suspected of drug use would be required to submit a blood, hair, urine, or saliva sample for analysis. Of these drug screening methods, only urine and saliva remain suitable for routine workplace drug screening due to their speed and convenience. Although…
Discover how the Intelligent Fingerprinting Drug Testing Solution works via our easy-to-follow fingerprint drug testing demo. The Intelligent Fingerprinting Drug Screening System is quick and easy to use, detecting commonly abused drugs via the fingertips. Sample collection takes less than a minute, and results are available within ten minutes. The system’s ease of use and…
